HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells-Reference-Cited by-同舟云学术

HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells

Published:2017-05-19 Issue:6 Volume:108 Page:1177-1184
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Bai Jingchao¹²³^ORCID,Zhou Guanglin¹²³,Qiu Yufan¹²³,Hu Yunhui¹²³,Liu Jingjing¹²³,Zhao Jing¹²³⁴,Zhang Sheng¹²³,Zhang Jin¹²³

Affiliation:

1. Third Department of Breast Cancer; Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin China

2. Tianjin's Clinical Research Center for Cancer; Tianjin China

3. Key Laboratory of Breast Cancer Prevention and Therapy; Tianjin Medical University; Ministry of Education; Tianjin China

4. Department of Lymphoma; Tianjin Medical university Cancer Hospital; Sino-US Center for Lymphoma and Leukemia; Tianjin Key Laboratory of Cancer Prevention and Therapy; Tianjin China

Funder

National Science and Technology Support Program

Tianjin Municipal Major Scientific and Technological Special Project for Significant Anticancer Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13238/fullpdf

Reference30 articles.

1. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

2. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer;Miller;J Clin Invest,2010